Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/20/2012WO2012097429A8 Probiotic soft gel compositions
09/20/2012WO2012095500A3 Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration
09/20/2012WO2012093971A3 Effervescent compositions comprising amlodipine
09/20/2012WO2012093404A8 Parenteral formulations of levosimendan
09/20/2012WO2012092339A3 The design of hydrolytically releasable prodrugs for sustained release nanoparticle formulations
09/20/2012WO2012089175A3 Traditional chinese medicinal tea made by microbial fermentation method
09/20/2012WO2012085284A3 High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
09/20/2012WO2012072977A8 Formulations comprising methylthioninium chloride
09/20/2012WO2012060790A3 Water dispersible cefpodoxime proxetil formulations
09/20/2012WO2012031175A9 Nanoparticle-based tumor-targeted drug delivery
09/20/2012US20120239007 Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners
09/20/2012US20120238943 Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
09/20/2012US20120238940 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
09/20/2012US20120238747 Transfection reagents
09/20/2012US20120238633 Hypotensive lipid-containing biodegradable intraocular implants and related methods
09/20/2012US20120238631 Compositions comprising cyclohexylamines and aminoadamantanes
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238555 Pharmaceutical composition containing irbesartan
09/20/2012US20120237666 Preformulation for Tabletting Natural Mixtures of Conjugated Estrogens
09/20/2012US20120237606 Hollow particulate body
09/20/2012US20120237605 Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same
09/20/2012US20120237604 Stable fat-soluble active principle particles
09/20/2012US20120237603 Abuse-resistant opioid dosage form
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237601 Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
09/20/2012US20120237600 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents
09/20/2012US20120237599 Enterically coated cysteamine, cystamine and derivatives thereof
09/20/2012US20120237598 Anti-constipation composition
09/20/2012US20120237597 Method for treating psoriasis
09/20/2012US20120237596 Nutrient delivery drug composition
09/20/2012US20120237595 Methods for treating amyloidosis using 4-(amino)-2-(2,6-dioxo(3-piperidyl))- isoindoline-1,3-dione
09/20/2012US20120237594 Methods of treating hypertriglyceridemia
09/20/2012US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use
09/20/2012US20120237592 Endoplasmic reticulum targeting liposomes
09/20/2012US20120237591 Modified drugs for use in liposomal nanoparticles
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237589 Amphoteric liposomes comprising imino lipids
09/20/2012US20120237588 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
09/20/2012US20120237587 Combination preparation including a corticosteroid and exosomes
09/20/2012US20120237586 Material for induction of hard tissue regeneration
09/20/2012US20120237585 Adhesive Composition For Carrying Therapeutic Agents As Delivery Vehicle On Coatings Applied To Vascular Grafts
09/20/2012US20120237584 Silver-containing antimicrobial articles and methods of manufacture
09/20/2012US20120237581 Method Of Producing A Silicone Powder-Containing Oil Composition
09/20/2012US20120237579 Hydrogel compositions with an erodible backing member
09/20/2012US20120237578 Microcapsules produced from blended sol-gel precursors and method for producing the same
09/20/2012US20120237575 Film coating agent for solid preparation, and solid preparation using same
09/20/2012US20120237574 Delayed-release formulation for reducing the frequency of urination and method of use thereof
09/20/2012US20120237573 Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
09/20/2012US20120237572 Antiviral composition comprising a sulfated polysaccharide
09/20/2012US20120237571 Sustained release compositions of alfuzosin
09/20/2012US20120237570 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
09/20/2012US20120237569 Emulsified composition for dilution and cancer vaccine composition
09/20/2012US20120237568 Bioactive Load-Bearing Composites
09/20/2012US20120237567 Modulating lymphatic function
09/20/2012US20120237566 Inhibiting stomach-acid release, reducing inflammation and preventing and treating cancer: compositions and methods of use
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237564 Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
09/20/2012US20120237563 Controlled-release formulations of anabaseine compounds and uses thereof
09/20/2012US20120237562 Antibiotic drug delivery and potentiation
09/20/2012US20120237561 injectable formulations containing asenapine and method of treatment using same
09/20/2012US20120237560 Cardiac Compositions
09/20/2012US20120237559 Formulations and methods for treating rhinosinusitis
09/20/2012US20120237558 Method of treating an osteochondral defect
09/20/2012US20120237557 Bioactive carbon-nanotube agarose composites for neural engineering
09/20/2012US20120237556 Topical base and active agent-containing compositions, and methods for improving and treating skin
09/20/2012US20120237555 Surface coating for biomolecule immobilisation and minimisation of non-specific binding on surfaces for biomedical diagnostics
09/20/2012US20120237548 Pharmaceutical compositions containing botulinum neurotoxin
09/20/2012US20120237456 Oral compositions containing extracts of garcinia mangostana l. and related methods
09/20/2012US20120237455 Oral compositions containing extracts of zizyphus joazeiro and related methods
09/20/2012US20120237454 Means and Methods for Preventing and/or Treating Caries
09/20/2012US20120237453 Sensation modifying topical composition foam
09/20/2012US20120237447 Star polymer nanoshells and methods of preparation thereof
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012US20120233929 Method of inhibiting water adsorption of powder by addition of hydrophobic nanaoparticles
09/20/2012CA2830298A1 Topical nitric oxide systems and methods of use thereof
09/20/2012CA2830165A1 Method for treating neurotrauma
09/20/2012CA2829832A1 Use of a sprayable composition comprising ambroxol
09/20/2012CA2829825A1 Colonoscopy - preparation
09/20/2012CA2829792A1 Treatment of vaginal atrophy as novel indication for myrrh
09/20/2012CA2829770A1 Denture adhesive remover for intraoral and extraoral use
09/20/2012CA2829164A1 An ophthalmic composition
09/20/2012CA2828747A1 Porous disintegratable solid substrate for personal health care applications
09/20/2012CA2828622A1 Vaccine formulation of mannose coated peptide particles
09/19/2012EP2500348A1 Phospholipid derivative and ph-responsive liposomes
09/19/2012EP2500062A2 C-19 steroids for specific therapeutic uses
09/19/2012EP2500038A1 Pharmaceutical composition for external use
09/19/2012EP2500026A1 Treatment of menopausal symptoms as novel indication for myrrh
09/19/2012EP2500023A1 Antibiotics composition comprising beta-lactam antibiotic, beta-lactamase inhibitor, and buffer component
09/19/2012EP2500016A1 Doxylamine resinate complex
09/19/2012EP2500015A1 Delivery of drugs
09/19/2012EP2500014A2 Slow release pharmaceutical composition made of microparticles
09/19/2012EP2500013A1 Pharmaceutical composition comprising solifenacin
09/19/2012EP2499914A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2499913A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2498903A2 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing
09/19/2012EP2498820A2 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
09/19/2012EP2498819A2 Topical etoricoxib formulation comprsing an eutectic mixture of permeation enhancers
09/19/2012EP2498818A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
09/19/2012EP2498805A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding
09/19/2012EP2498798A1 Compositions and methods for wound treatment
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 2991